Beside subtype defining rearrangements, other previously described translocations could be identified, including 8 rearrangements involving ZNF384, which were recently described to constitute a new molecular subtype of BCP-ALL ‘other’ with a good response to prednisone and conventional chemotherapy [43–45]. This evidence concerns the gene ZNF384 and acute lymphoblastic leukemia.